688293 奥浦迈
已收盘 09-11 15:00:00
资讯
新帖
简况
每周股票复盘：奥浦迈（688293）因股价涨幅达15%登龙虎榜
证券之星 · 02:25
每周股票复盘：奥浦迈（688293）因股价涨幅达15%登龙虎榜
9月10日奥浦迈跌5.80%，招商医药健康产业股票基金重仓该股
证券之星 · 09-10
9月10日奥浦迈跌5.80%，招商医药健康产业股票基金重仓该股
9月8日奥浦迈（688293）龙虎榜数据：机构净买入5350.29万元，北向资金净买入734.85万元
证券之星 · 09-08
9月8日奥浦迈（688293）龙虎榜数据：机构净买入5350.29万元，北向资金净买入734.85万元
9月8日奥浦迈涨20.00%，招商医药健康产业股票基金重仓该股
证券之星 · 09-08
9月8日奥浦迈涨20.00%，招商医药健康产业股票基金重仓该股
异动快报：奥浦迈（688293）9月8日14点6分触及涨停板
证券之星 · 09-08
异动快报：奥浦迈（688293）9月8日14点6分触及涨停板
电子、医药行业成公募上周调研焦点，富国、鹏华基金等旗下百亿基金经理现身
澎湃新闻 · 09-07
电子、医药行业成公募上周调研焦点，富国、鹏华基金等旗下百亿基金经理现身
奥浦迈：8月31日召开分析师会议，北京信复创值投资管理有限公司、平安证券股份有限公司等多家机构参与
证券之星 · 09-07
奥浦迈：8月31日召开分析师会议，北京信复创值投资管理有限公司、平安证券股份有限公司等多家机构参与
每周股票复盘：奥浦迈（688293）H1营收增155.24%，净利增230.34%
证券之星 · 09-06
每周股票复盘：奥浦迈（688293）H1营收增155.24%，净利增230.34%
9月2日奥浦迈发布公告，股东减持104.69万股
证券之星 · 09-02
9月2日奥浦迈发布公告，股东减持104.69万股
股市必读：奥浦迈新发布《奥浦迈：第二届董事会第二十六次会议决议公告》
证券之星 · 09-02
股市必读：奥浦迈新发布《奥浦迈：第二届董事会第二十六次会议决议公告》
奥浦迈（688293）2026年中报简析：营收净利润同比双双增长，三费占比上升明显
证券之星 · 09-01
奥浦迈（688293）2026年中报简析：营收净利润同比双双增长，三费占比上升明显
股市必读：奥浦迈新发布《奥浦迈：第二届董事会第二十五次会议决议公告》
证券之星 · 09-01
股市必读：奥浦迈新发布《奥浦迈：第二届董事会第二十五次会议决议公告》
奥浦迈（688293）披露2026年半年度报告，8月31日股价下跌3.63%
证券之星 · 08-31
奥浦迈（688293）披露2026年半年度报告，8月31日股价下跌3.63%
图解奥浦迈中报：第二季度单季净利润同比增长270.66%
证券之星 · 08-30
图解奥浦迈中报：第二季度单季净利润同比增长270.66%
奥浦迈(688293)6月30日股东户数0.6万户，较上期增加23.2%
证券之星 · 08-30
奥浦迈(688293)6月30日股东户数0.6万户，较上期增加23.2%
每周股票复盘：奥浦迈（688293）现2笔大宗交易机构净买入542.9万元
证券之星 · 08-30
每周股票复盘：奥浦迈（688293）现2笔大宗交易机构净买入542.9万元
8月25日奥浦迈现2笔大宗交易 机构净买入542.9万元
证券之星 · 08-25
8月25日奥浦迈现2笔大宗交易 机构净买入542.9万元
股市必读：8月21日奥浦迈现4笔大宗交易 机构净买入806.4万元
证券之星 · 08-24
股市必读：8月21日奥浦迈现4笔大宗交易 机构净买入806.4万元
每周股票复盘：奥浦迈（688293）周内现多笔大宗交易
证券之星 · 08-23
每周股票复盘：奥浦迈（688293）周内现多笔大宗交易
股市必读：8月20日奥浦迈现203.53万元大宗交易
证券之星 · 08-21
股市必读：8月20日奥浦迈现203.53万元大宗交易
加载更多
公司概况
公司名称：
上海奥浦迈生物科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2022-09-02
主营业务：
上海奥浦迈生物科技股份有限公司的主营业务是细胞培养产品与服务。公司的主要产品是细胞培养产品、CDMO服务、药物临床前CRO服务、医疗器械临床前CRO服务、实验动物销售、租赁及相关服务。截至2026年6月30日，公司拥有已授权的知识产权合计281项，其中，发明专利32项，实用新型专利100项，外观设计专利2项，软件著作权66项及其他81项。
发行价格：
80.20
{"stockData":{"symbol":"688293","market":"SH","secType":"STK","nameCN":"奥浦迈","latestPrice":65.1,"timestamp":1789110000000,"preClose":66.86,"halted":0,"volume":4394450,"delay":0,"changeRate":-0.0263,"floatShares":117000000,"shares":142000000,"eps":0.9015,"marketStatus":"已收盘","change":-1.76,"latestTime":"09-11 15:00:00","open":66.5,"high":68.74,"low":63.3,"amount":286000000,"amplitude":0.0814,"askPrice":65.15,"askSize":72,"bidPrice":65.1,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.9015,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":5,"adr":0,"adjPreClose":66.86,"symbolType":"stock_kcb","openAndCloseTimeList":[[1789090200000,1789097400000],[1789102800000,1789110000000]],"highLimit":73.55,"lowLimit":60.17,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":142194199,"isCdr":false,"pbRate":2.95,"roa":"--","peRate":72.212978,"roe":"4.32%","epsLYR":0.37,"committee":-0.038462,"marketValue":9257000000,"turnoverRate":0.0375,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-09-14。","afterMarket":{"amount":119588.7,"volume":1837,"close":65.1,"buyVolume":0,"sellVolume":532,"time":1789112037746,"indexStatus":"已收盘 09-11 15:30:00","preClose":66.86},"floatMarketCap":7627000000},"requestUrl":"/m/hq/s/688293","defaultTab":"news","newsList":[{"id":"2667507465","title":"每周股票复盘：奥浦迈（688293）因股价涨幅达15%登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2667507465","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667507465?lang=zh_cn&edition=full","pubTime":"2026-09-13 02:25","pubTimestamp":1789237513,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，奥浦迈报收于65.1元，较上周的54.62元上涨19.19%。本周，奥浦迈9月9日盘中最高价报73.15元，股价触及近一年最高点。本周关注点来自交易信息汇总：奥浦迈因日收盘价格涨幅达到15%登上龙虎榜。此次是近5个交易日内第1次上榜。其原定任期至2026年10月16日。在公司股东会选举产生新任独立董事前，文光伟先生将继续履行相关职责。公司董事会对文光伟先生在任职期间的贡献表示感谢。截至公告日，文光伟先生未持有公司股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666566449","title":"9月10日奥浦迈跌5.80%，招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666566449","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666566449?lang=zh_cn&edition=full","pubTime":"2026-09-10 16:37","pubTimestamp":1789029461,"startTime":"0","endTime":"0","summary":"证券之星消息，9月10日奥浦迈跌5.80%，收盘报66.86元，换手率5.6%，成交量6.56万手，成交额4.42亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共21家，其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。招商医药健康产业股票的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000029183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665329497","title":"9月8日奥浦迈（688293）龙虎榜数据：机构净买入5350.29万元，北向资金净买入734.85万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665329497","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665329497?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:53","pubTimestamp":1788861184,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年9月8日公布的交易公开信息显示，奥浦迈因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年9月8日收盘，奥浦迈报收于68.29元，上涨20.0%，涨停，换手率7.29%，成交量8.54万手，成交额5.32亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入5350.29万元，北向资金合计净买入734.85万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800027751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665532516","title":"9月8日奥浦迈涨20.00%，招商医药健康产业股票基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665532516","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665532516?lang=zh_cn&edition=full","pubTime":"2026-09-08 16:39","pubTimestamp":1788856795,"startTime":"0","endTime":"0","summary":"证券之星消息，9月8日奥浦迈涨20.00%，收盘报68.29元，换手率7.29%，成交量8.54万手，成交额5.32亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共21家，其中持有数量最多的公募基金为招商基金的招商医药健康产业股票。招商医药健康产业股票的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800026124.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665834718","title":"异动快报：奥浦迈（688293）9月8日14点6分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2665834718","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665834718?lang=zh_cn&edition=full","pubTime":"2026-09-08 14:15","pubTimestamp":1788848130,"startTime":"0","endTime":"0","summary":"证券之星9月8日盘中消息，14点6分奥浦迈（688293）触及涨停板。其所属行业生物制品目前上涨。领涨股为奥浦迈。该股为医药，创新药概念热股，当日医药概念上涨1.75%，创新药概念上涨1.59%。9月7日的资金流向数据方面，主力资金净流入1262.34万元，占总成交额5.95%，游资资金净流入32.97万元，占总成交额0.16%，散户资金净流出1295.32万元，占总成交额6.11%。近5日资金流向一览见下表：奥浦迈主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800018748.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665315098","title":"电子、医药行业成公募上周调研焦点，富国、鹏华基金等旗下百亿基金经理现身","url":"https://stock-news.laohu8.com/highlight/detail?id=2665315098","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665315098?lang=zh_cn&edition=full","pubTime":"2026-09-07 18:20","pubTimestamp":1788776400,"startTime":"0","endTime":"0","summary":"公募机构及百亿基金经理最新调研动向揭晓。公募排排网数据显示，上周（2026年8月31日-9月6日）共有142家公募机构参与A股调研活动中，覆盖到27个申万一级行业中的175只个股，合计调研次数达1428次，延续了较高的调研热情。从行业分布看，公募机构对11个行业的调研不少于50次。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609073866808185.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609073866808185.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0650527681.SGD","BK0077","LU1688375341.USD","LU2153592121.USD","IE0008368742.USD","LU0594300419.USD","002507","300661","BK0224","LU0084288322.USD","688800","LU0594300179.USD","BK0187","BK0028","LU1997245177.USD","000636","688322","IE0031814852.USD","LU0359201612.USD","BK0279","IE00BZ08YR35.GBP","300760","BK0109","LU2348774022.SGD","BK0125","BK0216","LU0823426308.USD","301345","BK0012","LU1720050803.USD","LU2039709279.SGD","LU0405327494.USD","IE00BZ08YT58.USD","LU2488822045.USD","IE00B031J352.USD","LU2153591404.USD","300900","300498","002270","LU1997245094.SGD","LU0823426480.USD","LU0359202008.SGD","001232","LU1813983027.USD","LU1934453819.USD","688293","LU1794554557.SGD","LU1328277881.USD","LU2424517915.HKD","BK0226"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665311465","title":"奥浦迈：8月31日召开分析师会议，北京信复创值投资管理有限公司、平安证券股份有限公司等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2665311465","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665311465?lang=zh_cn&edition=full","pubTime":"2026-09-07 17:41","pubTimestamp":1788774075,"startTime":"0","endTime":"0","summary":"答：截至2026年第二季度末,共有18个商业化管线使用奥浦迈的细胞培养基,商业化管线收入贡献接近40%,且占比逐年上升。目前奥浦迈在国内细胞培养行业处于绝对领先地位,过去几年,受客户商业化节奏波动及部分靶点药物市场规模限制等因素影响,客户管线整体尚未放量至销售峰值。2026年上半年,公司细胞培养业务呈现快速增长态势。目前公司已披露的管线数据尚未包含海外管线,但海外客户对奥浦迈产品品质与供应链稳定性认可度逐步提高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700022803.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665536560","title":"每周股票复盘：奥浦迈（688293）H1营收增155.24%，净利增230.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665536560","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665536560?lang=zh_cn&edition=full","pubTime":"2026-09-06 01:47","pubTimestamp":1788630431,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，奥浦迈报收于54.62元，较上周的55.1元下跌0.87%。本周，奥浦迈9月2日盘中最高价报58.44元。本周关注点来自业绩披露要点：奥浦迈2026年上半年实现营收453,690,008.08元，同比增长155.24%。来自业绩披露要点：归母净利润为124,032,624.39元，同比增长230.34%。中期利润分配拟每10股派发现金红利2.00元（含税），合计派发28,438,839.80元，占当期归母净利润的22.93%。作废已授予但未归属的限制性股票合计22,400股，涉及离职及考核不达标人员。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664890486","title":"9月2日奥浦迈发布公告，股东减持104.69万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664890486","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664890486?lang=zh_cn&edition=full","pubTime":"2026-09-02 17:27","pubTimestamp":1788341256,"startTime":"0","endTime":"0","summary":"证券之星消息，9月2日奥浦迈发布公告《奥浦迈:关于股东减持股份结果公告》，其股东北京磐茂投资管理有限公司-磐信(上海)投资中心(有限合伙)于2026年8月8日至2026年9月1日间合计减持104.69万股，占公司目前总股本的0.7362%，变动期间该股股价下跌15.28%，截止9月1日收盘报53.56元。股东增减持详情见下表：根据奥浦迈2026年中报公布的十大股东详情如下：本文数据来源于奥浦迈公告，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200030914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664865077","title":"股市必读：奥浦迈新发布《奥浦迈：第二届董事会第二十六次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664865077","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664865077?lang=zh_cn&edition=full","pubTime":"2026-09-02 03:13","pubTimestamp":1788289990,"startTime":"0","endTime":"0","summary":"公司公告汇总奥浦迈：第二届董事会第二十六次会议决议公告上海奥浦迈生物科技股份有限公司第二届董事会第二十六次会议于2026年9月1日以通讯方式召开，审议通过三项议案：调整公司2023年限制性股票激励计划授予价格至23.71元/股；作废已授予但尚未归属的限制性股票22,400股；确认2023年限制性股票激励计划首次授予部分第三个归属期及预留授予部分第二个归属期符合归属条件，共计312,000股可归属。关联董事回避表决，会议决议合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200002756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664885235","title":"奥浦迈（688293）2026年中报简析：营收净利润同比双双增长，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2664885235","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664885235?lang=zh_cn&edition=full","pubTime":"2026-09-01 06:10","pubTimestamp":1788214221,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期奥浦迈发布2026年中报。截至本报告期末，公司营业总收入4.54亿元，同比上升155.24%，归母净利润1.24亿元，同比上升230.34%。本报告期奥浦迈三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达31.26%。持有奥浦迈最多的基金为招商医药健康产业股票，目前规模为12.99亿元，最新净值2.487，较上一交易日下跌1.0%，近一年上涨25.16%。本文数据来源于奥浦迈2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100004826.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664830000","title":"股市必读：奥浦迈新发布《奥浦迈：第二届董事会第二十五次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664830000","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664830000?lang=zh_cn&edition=full","pubTime":"2026-09-01 02:13","pubTimestamp":1788199989,"startTime":"0","endTime":"0","summary":"奥浦迈：关于续聘公司会计师事务所的公告2026年8月27日召开第二届董事会第二十五次会议，审议通过续聘立信会计师事务所为公司2026年度财务审计机构及内部控制审计机构。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100002297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663207282","title":"奥浦迈（688293）披露2026年半年度报告，8月31日股价下跌3.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663207282","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663207282?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:29","pubTimestamp":1788172197,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，奥浦迈报收于53.1元，较前一交易日下跌3.63%，最新总市值为75.51亿元。奥浦迈于2026年8月31日披露《2026年半年度报告》。公司拟以权益分派实施股权登记日的股份总数为基数，向全体股东每10股派发现金红利人民币2.00元（含税），预计分配现金红利28,438,839.80元（含税），占公司2026年半年度合并报表归属于上市公司股东净利润的22.93%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100028452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663490380","title":"图解奥浦迈中报：第二季度单季净利润同比增长270.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663490380","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663490380?lang=zh_cn&edition=full","pubTime":"2026-08-30 17:37","pubTimestamp":1788082637,"startTime":"0","endTime":"0","summary":"证券之星消息，奥浦迈2026年中报显示，上半年度公司主营收入4.54亿元，同比上升155.24%；归母净利润1.24亿元，同比上升230.34%；扣非净利润4935.72万元，同比上升66.87%；其中2026年第二季度，公司单季度主营收入2.72亿元，同比上升188.65%；单季度归母净利润8480.37万元，同比上升270.66%；单季度扣非净利润4476.39万元，同比上升138.39%；负债率16.02%，投资收益620.8万元，财务费用273.08万元，毛利率46.05%。财报数据概要请见下图:本文数据来源于奥浦迈2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000012866.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663049450","title":"奥浦迈(688293)6月30日股东户数0.6万户，较上期增加23.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663049450","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663049450?lang=zh_cn&edition=full","pubTime":"2026-08-30 17:07","pubTimestamp":1788080872,"startTime":"0","endTime":"0","summary":"证券之星消息，近日奥浦迈披露，截至2026年6月30日公司股东户数为6012.0户，较3月31日增加1132.0户，增幅为23.2%。在生物制品行业个股中，奥浦迈股东户数低于行业平均水平，截至6月30日，生物制品行业平均股东户数为3.54万户。从股价来看，2026年3月31日至2026年6月30日，奥浦迈区间跌幅为3.05%，在此期间股东户数增加1132.0户，增幅为23.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000011126.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663102050","title":"每周股票复盘：奥浦迈（688293）现2笔大宗交易机构净买入542.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2663102050","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663102050?lang=zh_cn&edition=full","pubTime":"2026-08-30 04:12","pubTimestamp":1788034332,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，奥浦迈（688293）报收于55.1元，较上周的61.75元下跌10.77%。本周，奥浦迈8月24日盘中最高价报62.57元。8月28日盘中最低价报54.94元。奥浦迈当前最新总市值78.35亿元，在生物制品板块市值排名32/51，在两市A股市值排名2238/5211。本周关注点来自交易信息汇总：8月25日奥浦迈现2笔大宗交易，机构净买入542.9万元交易信息汇总8月25日奥浦迈现2笔大宗交易，机构净买入542.9万元以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688293"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662273651","title":"8月25日奥浦迈现2笔大宗交易 机构净买入542.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662273651","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662273651?lang=zh_cn&edition=full","pubTime":"2026-08-25 18:48","pubTimestamp":1787654885,"startTime":"0","endTime":"0","summary":"证券之星消息，8月25日奥浦迈发生大宗交易，交易数据如下：近三个月该股共发生31笔大宗交易，合计成交4.07万手，折价成交31笔。该股在过去半年内已有共计331.91万股限售解禁股上市，占公司总股本的2.33%。截至2026年8月25日收盘，奥浦迈(688293)报收于59.33元，上涨1.98%，换手率3.58%，成交量4.19万手，成交额2.46亿元。该股近半年内有股东持股变动，合计净减持405.97万股，股东增减持明细如下表：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家。本文数据来源于上海证券交易所大宗交易信息披露，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500039793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661245606","title":"股市必读：8月21日奥浦迈现4笔大宗交易 机构净买入806.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661245606","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661245606?lang=zh_cn&edition=full","pubTime":"2026-08-24 02:53","pubTimestamp":1787511189,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，奥浦迈报收于61.75元，下跌3.36%，换手率3.88%，成交量4.55万手，成交额2.81亿元。当日关注点交易信息汇总：8月21日奥浦迈主力资金净流出664.87万元，游资资金净流入830.33万元；当日现4笔大宗交易，机构净买入806.4万元。大宗交易8月21日奥浦迈现4笔大宗交易，机构净买入806.4万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400001279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661214836","title":"每周股票复盘：奥浦迈（688293）周内现多笔大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2661214836","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661214836?lang=zh_cn&edition=full","pubTime":"2026-08-23 03:05","pubTimestamp":1787425513,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，奥浦迈报收于61.75元，较上周的66.37元下跌6.96%。本周，奥浦迈8月17日盘中最高价报67.46元。8月19日盘中最低价报59.87元。奥浦迈当前最新总市值87.8亿元，在生物制品板块市值排名31/51，在两市A股市值排名2013/5210。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661523609","title":"股市必读：8月20日奥浦迈现203.53万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2661523609","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661523609?lang=zh_cn&edition=full","pubTime":"2026-08-21 00:50","pubTimestamp":1787244620,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘，奥浦迈报收于63.9元，上涨5.83%，换手率5.59%，成交量6.54万手，成交额4.18亿元。当日关注点交易信息汇总：8月20日主力资金净流入4369.74万元，占总成交额10.44%。交易信息汇总：当日发生203.53万元大宗交易。大宗交易8月20日奥浦迈发生203.53万元大宗交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100000813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688293","BK0216"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789301650360,"stockEarnings":[{"period":"1week","weight":0.1919},{"period":"1month","weight":0.0527},{"period":"3month","weight":0.8278},{"period":"6month","weight":0.3682},{"period":"1year","weight":0.274},{"period":"ytd","weight":0.3347}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":-0.0148},{"period":"3month","weight":-0.0356},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0033},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海奥浦迈生物科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"6012人(较上一季度增加23.20%)","perCapita":"19488股","listingDate":"2022-09-02","address":"上海市浦东新区紫萍路908弄28号","registeredCapital":"14219万元","survey":" 上海奥浦迈生物科技股份有限公司的主营业务是细胞培养产品与服务。公司的主要产品是细胞培养产品、CDMO服务、药物临床前CRO服务、医疗器械临床前CRO服务、实验动物销售、租赁及相关服务。截至2026年6月30日，公司拥有已授权的知识产权合计281项，其中，发明专利32项，实用新型专利100项，外观设计专利2项，软件著作权66项及其他81项。","listedPrice":80.2},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥浦迈(688293)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥浦迈(688293)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥浦迈,688293,奥浦迈股票,奥浦迈股票老虎,奥浦迈股票老虎国际,奥浦迈行情,奥浦迈股票行情,奥浦迈股价,奥浦迈股市,奥浦迈股票价格,奥浦迈股票交易,奥浦迈股票购买,奥浦迈股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥浦迈(688293)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥浦迈(688293)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}